IMMU
Immunomedics, Inc. Common Stock
stockNASDAQ
InactiveOct 22, 2020 4:00:00 PM EDT
87.86USD+0.046%(+0.04)
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
HQ
NJ, USA
IMMU Profile
Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
IMMU Performance
| Period | Price | Date | Change |
|---|